INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 132 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $5,132,000 | -86.4% | 336,759 | -65.3% | 0.41% | -88.7% |
Q2 2016 | $37,716,000 | +28.5% | 971,565 | -8.0% | 3.60% | +19.9% |
Q1 2016 | $29,358,000 | -55.4% | 1,056,059 | -13.7% | 3.00% | -39.0% |
Q4 2015 | $65,824,000 | +24.3% | 1,223,717 | -7.5% | 4.93% | +22.8% |
Q3 2015 | $52,957,000 | +171.6% | 1,322,592 | +116.8% | 4.01% | +151.1% |
Q2 2015 | $19,495,000 | +22.1% | 610,171 | -8.7% | 1.60% | +11.4% |
Q1 2015 | $15,968,000 | -8.7% | 668,671 | -32.5% | 1.43% | -24.7% |
Q4 2014 | $17,488,000 | +27.1% | 990,810 | -1.3% | 1.90% | +19.8% |
Q3 2014 | $13,758,000 | -16.7% | 1,003,496 | +2.5% | 1.59% | -20.7% |
Q2 2014 | $16,513,000 | -9.3% | 979,446 | -2.2% | 2.00% | -7.8% |
Q1 2014 | $18,199,000 | – | 1,001,060 | – | 2.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |